Access the full text.
Sign up today, get DeepDyve free for 14 days.
I. Gorlov, O. Gorlova, M. Frazier, C. Amos (2004)
Missense mutations in cancer suppressor gene TP53 are colocalized with exonic splicing enhancers (ESEs).Mutation research, 554 1-2
D. Easton, A. Deffenbaugh, D. Pruss, Cynthia Frye, R. Wenstrup, K. Allen-Brady, S. Tavtigian, A. Monteiro, E. Iversen, F. Couch, D. Goldgar (2007)
A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.American journal of human genetics, 81 5
M. Gallardo, Antonia Silva, L. Rubio, C. Alvarez, Carolina Torrealba, M. Salinas, Teresa Tapia, P. Faúndez, Lorena Palma, M. Riccio, Hernando Paredes, Mario Rodríguez, Adolfo Cruz, C. Rousseau, M. King, M. Camus, M. Álvarez, P. Carvallo (2005)
Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlationsBreast Cancer Research and Treatment, 95
P. Kozłowski, K. Sobczak, A. Jasinska, W. Krzyzosiak (2000)
Allelic imbalance of BRCA1 transcript in the IVS20 12‐bp insertion carrierHuman Mutation, 16
R. Wooster, G. Bignell, J. Lancaster, S. Swift, S. Seal, J. Mangion, N. Collins, S. Gregory, C. Gumbs, Gos Michlem, R. Barfoot, R. Hamoudi, Sandeep Patel, C. Rice, P. Biggs, Yasmin Hashim, Amanda Smith, F. Connor, A. Arason, J. Gudmundsson, D. Ficenec, D. Kelsell, D. Ford, P. Tonin, D. Bishop, N. Spurr, B. Ponder, R. Eeles, J. Peto, P. Devilee, C. Cornelisse, H. Lynch, S. Narod, G. Lenoir, V. Egilsson, Rosa Barkadottir, D. Easton, D. Bentley, P. Futreal, A. Ashworth, M. Stratton (1996)
Identification of the breast cancer susceptibility gene BRCA2Nature, 379
E. Takano, G. Mitchell, S. Fox, A. Dobrovic (2008)
Rapid detection of carriers with BRCA1 and BRCA2 mutations using high resolution melting analysisBMC Cancer, 8
Nebojsa Mirkovic, M. Martí-Renom, B. Weber, A. Sali, A. Monteiro (2004)
Structure-Based Assessment of Missense Mutations in Human BRCA1Cancer Research, 64
A. Antoniou, P. Pharoah, S. Narod, H. Risch, J. Eyfjord, J. Hopper, N. Loman, Hampus Olsson, O. Johannsson, Å. Borg, B. Pasini, P. Radice, S. Manoukian, D. Eccles, N. Tang, E. Oláh, H. Anton-Culver, E. Warner, J. Lubiński, J. Gronwald, B. Górski, H. Tulinius, S. Thorlacius, H. Eerola, H. Nevanlinna, K. Syrjäkoski, O. Kallioniemi, Deborah Thompson, Chris Evans, J. Peto, F. Lalloo, D. Evans, D. Easton (2003)
Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.American journal of human genetics, 72 5
S. Saxena, A. Chakraborty, M. Kaushal, S. Kotwal, Dinesh Bhatanager, R. Mohil, C. Chintamani, Anil Aggarwal, V. Sharma, P. Sharma, G. Lenoir, D. Goldgar, C. Szabo (2006)
Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern IndiaBMC Medical Genetics, 7
Kangjian Wu, S. Hinson, A. Ohashi, Daniel Farrugia, Patrícia Wendt, S. Tavtigian, A. Deffenbaugh, D. Goldgar, F. Couch (2005)
Functional evaluation and cancer risk assessment of BRCA2 unclassified variants.Cancer research, 65 2
J. Barrett, B. Fry, J. Maller, M. Daly (2005)
Haploview: analysis and visualization of LD and haplotype mapsBioinformatics, 21 2
D. Easton, A. Antoniou, Deborah Thompson, C. Isaacs, T. Rebbeck (2007)
The Genetic Epidemiology of Hereditary Breast Cancer
K. Leeneer, I. Coene, B. Poppe, A. Paepe, K. Claes (2008)
Rapid and sensitive detection of BRCA1/2 mutations in a diagnostic setting: comparison of two high-resolution melting platforms.Clinical chemistry, 54 6
N. Ikeda, Y. Miyoshi, K. Yoneda, E. Shiba, Yoshizo Sekihara, M. Kinoshita, S. Noguchi (2001)
Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer familiesInternational Journal of Cancer, 91
C. Szabo, M. King (1995)
Inherited breast and ovarian cancer.Human molecular genetics, 4 Spec No
L. Cartegni, Jinhua Wang, Zhengwei Zhu, Michael Zhang, A. Krainer (2003)
ESEfinder: a web resource to identify exonic splicing enhancersNucleic acids research, 31 13
M. Reese, F. Eeckman, D. Kulp, D. Haussler (1997)
Improved splice site detection in GenieJournal of computational biology : a journal of computational molecular cell biology, 4 3
BRCA1 and BRCA2 sequence variants in Croatia 1383
N. Arnold, H. Peper, K. Bandick, Maike Kreikemeier, D. Karow, Birgit Teegen, W. Jonat (2002)
Establishing a control population to screen for the occurrence of nineteen unclassified variants in the BRCA1 gene by denaturing high-performance liquid chromatography.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 782 1-2
S. Hahn, B. Greenhalf, I. Ellis, M. Sina‐Frey, H. Rieder, B. Korte, B. Gerdes, R. Kress, A. Ziegler, J. Raeburn, D. Campra, R. Grützmann, H. Rehder, M. Rothmund, W. Schmiegel, J. Neoptolemos, D. Bartsch (2003)
BRCA2 germline mutations in familial pancreatic carcinoma.Journal of the National Cancer Institute, 95 3
V. Abkevich, A. Zharkikh, A. Deffenbaugh, D. Frank, Y. Chen, D. Shattuck, M. Skolnick, A. Gutin, S. Tavtigian (2004)
Analysis of missense variation in human BRCA1 in the context of interspecific sequence variationJournal of Medical Genetics, 41
C. Capalbo, E. Ricevuto, A. Vestri, Elisabetta Ristori, T. Sidoni, O. Buffone, B. Adamo, E. Cortesi, P. Marchetti, G. Scambia, S. Tomao, Christian Rinaldi, M. Zani, S. Ferraro, L. Frati, I. Screpanti, A. Gulino, G. Giannini (2006)
BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction models.Annals of oncology : official journal of the European Society for Medical Oncology, 17 Suppl 7
Hong-Xiang Liu, L. Cartegni, Michael Zhang, A. Krainer (2001)
A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genesNature Genetics, 27
Ivica Letunic, R. Copley, Birgit Pils, Stefan Pinkert, J. Schultz, P. Bork (2005)
SMART 5: domains in the context of genomes and networksNucleic Acids Research, 34
G. Cipollini, S. Tommasi, A. Paradiso, P. Aretini, F. Bonatti, I. Brunetti, M. Bruno, G. Lombardi, F. Schittulli, E. Sensi, M. Tancredi, G. Bevilacqua, M. Caligo (2004)
Genetic alterations in hereditary breast cancer.Annals of oncology : official journal of the European Society for Medical Oncology, 15 Suppl 1
(1998)
Genetic heterogeneity and penetranceanalysis of the BRCA1 and BRCA2 genes in breast cancer families
P. Meyer, Theda Voigtlaender, C. Bartram, R. Klaes (2003)
Twenty‐three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern GermanyHuman Mutation, 22
L. Stuppia, P. Fulvio, G. Aceto, S. Pintor, S. Veschi, V. Gatta, Alessia Colosimo, Ettore Cianchetti, A. Cama, R. Mariani-Costantini, P. Battista, G. Palka (2003)
BRCA1 and BRCA2 mutations in breast/ovarian cancer patients from central ItalyHuman Mutation, 22
P. Ng, S. Henikoff (2003)
SIFT: predicting amino acid changes that affect protein functionNucleic acids research, 31 13
(2003)
Denaturing high performance liquid chromatography (DHPLC), an important mutation detection technique and mutation analysis of the breast and ovarian cancer predisposing genes BRCA1 and BRCA2
T. Judkins, B. Hendrickson, A. Deffenbaugh, K. Eliason, B. Leclair, Michael Norton, B. Ward, D. Pruss, T. Scholl (2005)
Application of embryonic lethal or other obvious phenotypes to characterize the clinical significance of genetic variants found in trans with known deleterious mutations.Cancer research, 65 21
Deborah Thompson, D. Easton (2001)
Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.American journal of human genetics, 68 2
Ioulia Belogianni, A. Apessos, M. Mihalatos, E. Razi, S. Labropoulos, A. Petounis, V. Gaki, A. Keramopoulos, N. Pandis, K. Kyriacou, A. Hadjisavvas, P. Kosmidis, D. Yannoukakos, G. Nasioulas (2004)
Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancerBMC Cancer, 4
A. Hadjisavvas, E. Charalambous, A. Adamou, C. Christodoulou, K. Kyriacou (2003)
BRCA2 germline mutations in Cypriot patients with familial breast/ovarian cancerHuman Mutation, 21
A. Russo, V. Caló, V. Agnese, L. Bruno, S. Corsale, C. Augello, G. Gargano, F. Barbera, S. Cascio, C. Intrivici, G. Rinaldi, G. Gulotta, M. Macaluso, E. Surmacz, A. Giordano, N. Gebbia, V. Bazan (2007)
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analysesBreast Cancer Research and Treatment, 105
S. Tommasi, A. Crapolicchio, R. Lacalamita, M. Bruno, A. Monaco, S. Petroni, F. Schittulli, S. Longo, M. Digennaro, D. Calistri, A. Mangia, A. Paradiso (2005)
BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy.Mutation research, 578 1-2
N. Howlett, T. Taniguchi, S. Olson, B. Cox, Q. Waisfisz, C. Die-Smulders, N. Persky, M. Grompe, H. Joenje, G. Pals, H. Ikeda, E. Fox, A. D’Andrea (2002)
Biallelic Inactivation of BRCA2 in Fanconi AnemiaScience, 297
C. Phelan, V. Dapíc, B. Tice, R. Favis, E. Kwan, F. Barany, S. Manoukian, P. Radice, R. Luijt, B. Nesselrooij, G. Chenevix-Trench, kConFab, T. Caldés, M. Hoya, S. Lindquist, S. Tavtigian, D. Goldgar, Å. Borg, S. Narod, A. Monteiro (2005)
Classification of BRCA1 missense variants of unknown clinical significanceJournal of Medical Genetics, 42
D. Goldgar, D. Easton, A. Deffenbaugh, A. Monteiro, S. Tavtigian, F. Couch (2004)
Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.American journal of human genetics, 75 4
Y. Miki, J. Swensen, D. Shattuck-Eidens, P. Futreal, K. Harshman, S. Tavtigian, Qingyun Liu, C. Cochran, L. Bennett, W. Ding, R. Bell, J. Rosenthal, C. Hussey, Thanh Tran, M. Mcclure, C. Frye, T. Hattier, R. Phelps, A. Haugen-Strano, H. Katcher, Kazuko Yakumo, Z. Gholami, Daniel Shaffer, S. Stone, Steven Bayer, Christian Wray, R. Bogden, P. Dayananth, J. Ward, P. Tonin, S. Narod, Pamela Bristow, F. Norris, L. Helvering, P. Morrison, P. Rosteck, Mei Lai, J. Barrett, C. Lewis, S. Neuhausen, L. Cannon-Albright, D. Goldgar, R. Wiseman, A. Kamb, M. Skolnick (1994)
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266 5182
M. Liew, R. Pryor, Robert Palais, Cindy Meadows, M. Erali, E. Lyon, C. Wittwer (2004)
Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons.Clinical chemistry, 50 7
D. Shen, J. Vadgama (1999)
BRCA1 and BRCA2 gene mutation analysis: visit to the Breast Cancer Information Core (BIC).Oncology research, 11 2
P. Aretini, E. D'andrea, B. Pasini, A. Viel, R. Costantini, L. Cortesi, E. Ricevuto, S. Agata, R. Bisegna, M. Boiocchi, M. Caligo, L. Chieco‐Bianchi, G. Cipollini, R. Crucianelli, C. D'amico, M. Federico, C. Ghimenti, C. Giacomi, A. Nicolo, L. Puppa, S. Ferrari, C. Ficorella, D. Iandolo, S. Manoukian, P. Marchetti, F. Marroni, C. Menin, M. Montagna, L. Ottini, V. Pensotti, M. Pierotti, P. Radice, M. Santarosa, V. Silingardi, D. Turchetti, G. Bevilacqua, S. Presciuttini (2003)
Different Expressivity of BRCA1 and BRCA2: Analysis of 179 Italian Pedigrees with Identified MutationBreast Cancer Research and Treatment, 81
J. Fackenthal, L. Cartegni, A. Krainer, O. Olopade (2002)
BRCA2 T2722R is a deleterious allele that causes exon skipping.American journal of human genetics, 71 3
Meghan Arnold, M. Goggins (2001)
BRCA2 and predisposition to pancreatic and other cancersExpert Reviews in Molecular Medicine, 3
A. Deffenbaugh, T. Frank, Michael Hoffman, L. Cannon-Albright, S. Neuhausen (2002)
Characterization of common BRCA1 and BRCA2 variants.Genetic testing, 6 2
J. Seo, D. Cho, S. Ahn, K. Yoon, Changwon Kang, Hyunmi Cho, Hyeon Lee, Jae Choe, Cheul Choi, Byungsoo Kim, S. Shin, Yeul-Hong Kim, Jun Kim, G. Son, Jae-Bok Lee, B. Koo (2004)
BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancerHuman Mutation, 24
A. Tutt, A. Ashworth (2002)
The relationship between the roles of BRCA genes in DNA repair and cancer predisposition.Trends in molecular medicine, 8 12
I. Konstantopoulou, T. Rampias, A. Ladopoulou, G. Koutsodontis, S. Armaou, T. Anagnostopoulos, G. Nikolopoulos, S. Kamakari, G. Nounesis, Antonis Stylianakis, C. Karanikiotis, E. Razis, H. Gogas, A. Keramopoulos, V. Gaki, C. Markopoulos, D. Skarlos, N. Pandis, T. Bei, I. Arzimanoglou, G. Fountzilas, D. Yannoukakos (2008)
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patientsBreast Cancer Research and Treatment, 107
V. Ramensky, P. Bork, S. Sunyaev (2002)
Human non-synonymous SNPs: server and survey.Nucleic acids research, 30 17
Christopher Pettigrew, Nicola Wayte, A. Wronski, P. Lovelock, A. Spurdle, Melissa Brown (2008)
Colocalisation of predicted exonic splicing enhancers in BRCA2 with reported sequence variantsBreast Cancer Research and Treatment, 110
Chuan-gui Song, Zhen Hu, Jiong Wu, Jian-Min Luo, Z. Shen, Wei Huang, Z. Shao (2006)
The prevalence of BRCA1 and BRCA2 mutations in eastern Chinese women with breast cancerJournal of Cancer Research and Clinical Oncology, 132
A. Meindl, B. Weber (2002)
Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German populationInternational Journal of Cancer, 97
S. Tavtigian, Amie Deffenbaugh, L. Yin, T. Judkins, T. Scholl, P. Samollow, D. Silva, A. Zharkikh, Alun Thomas (2005)
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutralJournal of Medical Genetics, 43
G. Reed, C. Wittwer (2004)
Sensitivity and specificity of single-nucleotide polymorphism scanning by high-resolution melting analysis.Clinical chemistry, 50 10
Abstract Background : Mutations in BRCA1 and BRCA2 genes are associated with family predisposition to breast and ovarian cancer. Novel screening methods are required for efficient and rapid detection of sequence variants in cancer patients and their family members. Methods : The screening for variants in the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 in Croatia was performed by a high-resolution melting approach, which is based on differences in melting curves caused by variations in nucleotide sequence. This is the first screening in Croatia on elderly healthy women with no family history of cancer. BRCA1 screening was performed on 220 and BRCA2 screening on 115 samples. Results : In a population well beyond the average age of breast/ovarian cancer onset, 21 different sequence variants in the BRCA1 gene (one novel: c.5193+49_50delTA ) and 36 variants in the BRCA2 gene (7 novel: c.459A>C , c.3318C>A , c.4412_ 4414delGAA , c.4790C>A , c.6264T>C , c.9087G>A , and c.9864A>G ) were detected. Conclusions : Nine BRCA1 and seven BRCA2 known variants appeared with such high frequencies that they could be declared as harmless in this population. Eight BRCA1 high frequency variants, located further from the promoter region, appear to be strongly correlated. Three novel variants that changed the amino acid sequence of the BRCA2 protein (two missense base substitutions, c.3318C>A and c.4790C>A , and one codon deletion c.4412_4414delGAA ), appearing only once, were predicted to have no potential effect on protein structure and function. Clin Chem Lab Med 2008;46:1376–83.
Clinical Chemistry and Laboratory Medicine (CCLM) – de Gruyter
Published: Oct 1, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.